Compare Gigacloud Technology Inc (GCT) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gigacloud Technology Inc vs Revvity Inc — how do they compare? Gigacloud Technology Inc trades at $57.26 (market cap $2.02B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: Revvity Inc is far larger — about 8.4× Gigacloud Technology Inc's market cap, and Revvity Inc pays a 0.18% dividend while Gigacloud Technology Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gigacloud Technology Inc for 21 Days and Revvity Inc for 12 Days on average.
| GCT | RVTY | |
|---|---|---|
Market Cap | $2.02B | $16.98B |
Volume | 1,020,985 | 1,456,900 |
Sector | Technology | Health |
52-Week High | $57.26 | $157.36 |
52-Week Low | $25.46 | $82.26 |
Typical Hold Time | 21 Days | 12 Days |
Enterprise Value | $2.14B | $19.30B |
Dividend Yield | — | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GCT trades at $56.42, up 0.82% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 10.65% net margins and consistent earnings beats, though the current price exceeds analyst consensus targets. Recent news highlights institutional interest and European expansion potential.
GCT offers growth potential through international expansion and strong execution but faces risks from insider selling and valuation concerns. The stock trades above most analyst targets, suggesting limited near-term upside despite solid fundamentals and positive technical indicators.
RVTY trades at $152.16, down 0.94% today, near its recent 52-week high of $158.28 (Defense World, 2026-10-01). The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for three consecutive quarters. Recent positive developments include a Zacks upgrade to Buy (2026-10-02) and the launch of a new Type 1 diabetes screening kit in Europe (Business Wire, 2026-09-24).
The outlook is positive, supported by earnings momentum and strategic expansions, but the stock's premium valuation (P/E of 73.15) and margin pressures pose risks. Analyst consensus is bullish with a $132.13 price target, though the current price exceeds it, suggesting near-term consolidation may occur before further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
